SYNAPTIQ TECHNOLOGIES SRL
Romania RO-MF-000038617 Last updated 21 Oct 2026
Is this your brand? Sign in to claim this brand
- Devices
- 2
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
EUDAMED certificates
TÜV Rheinland LGA Products GmbH 0197 1 certificate
- HZ 2447216-1 Issued
Quality management system EU MDR
- Issued
- 1 Apr 2026
- Expires
- 31 Mar 2031
Related companies
Notified bodies
About
Discover Mediq RT, a platform using AI for organs at risk and lymph nodes auto-contouring as part of radiotherapy treatment planning. Find out more!
What SYNAPTIQ TECHNOLOGIES SRL makes
Synaptiq Technologies SRL manufactures radiotherapy treatment planning software, including the Mediq and Mediq RT platforms. These tools incorporate artificial intelligence to automate the contouring of organs at risk and lymph nodes, supporting precision in radiation therapy workflows.
The company’s devices are classified as Class I and Class IIa under EU regulations and are listed in the EUDAMED database. Synaptiq Technologies SRL is based in Romania.
Frequently asked questions
What types of medical devices does Synaptiq Technologies SRL manufacture?
Synaptiq Technologies SRL develops radiotherapy treatment planning software, specifically the Mediq and Mediq RT platforms. These tools use artificial intelligence to automate the contouring of organs at risk and lymph nodes, which helps improve precision and efficiency in radiation therapy planning.
Where is Synaptiq Technologies SRL based?
Synaptiq Technologies SRL is based in Romania, as indicated in its regulatory information.
Which regulatory registries list Synaptiq Technologies SRL’s devices?
Synaptiq Technologies SRL’s devices are listed in the EUDAMED database, which is the European Union’s medical device registry. This listing ensures transparency and compliance with EU regulatory requirements.
How are Synaptiq Technologies SRL’s devices classified under EU regulations?
Synaptiq Technologies SRL’s devices are classified as Class I and Class IIa under EU medical device regulations. The classification depends on factors like the device’s intended purpose, risk level, and interaction with the patient, with Class IIa indicating a moderate risk requiring additional scrutiny.
Information
- Country
- Romania
- Address
- 23a, Clinicilor, Cluj-Napoca, Romania
- Website
- synaptiq.io
- linkedin.com/company/synaptiq-io
- facebook.com/synaptiq.io
- [email protected]
- PRRC contact
- Andreea-Maria Mitrofan
- EUDAMED SRN
- RO-MF-000038617